you are here:

Aarti Drugs Ltd.

BSE: 524348 | NSE: AARTIDRUGS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE767A01016 | SECTOR: Pharmaceuticals

BSE Live

Jan 21, 16:00
494.85 -9.90 (-1.96%)
Volume
AVERAGE VOLUME
5-Day
27,734
10-Day
20,511
30-Day
19,650
49,811
  • Prev. Close

    504.75

  • Open Price

    502.60

  • Bid Price (Qty.)

    497.00 (10)

  • Offer Price (Qty.)

    506.00 (460)

NSE Live

Jan 21, 15:59
495.15 -9.60 (-1.90%)
Volume
AVERAGE VOLUME
5-Day
112,795
10-Day
116,557
30-Day
182,246
179,940
  • Prev. Close

    504.75

  • Open Price

    505.00

  • Bid Price (Qty.)

    495.15 (3)

  • Offer Price (Qty.)

    0.00 (0)

Company History - Aarti Drugs
Aarti Drugs Limited was incorporated on 28th September, 1984 as a
 Private Limited Company. It was converted into a Public Limited
 Company on 1st July, 1992.
 
 The  Company is presently engaged in the manufacture of MNI(300 TPA),
 MTZ (96 TPA), TNZ (84 TPA), DMZ (90 TPA)  and Isoniazid (INH) (96
 TPA). The   Company  started its commercial production is March 1987
 at G.I.D.C. Industrial Estate, Sarigam, Dist. Valsad,  Gujarat. This
 project  was put up with   financial assistance from Gujarat State
 Finance Corporation (GSFC) and Gujarat Industrial  Investment
 Corporation (GIIC).
 
 The Company  now  proposes  to expand the capacities for the above
 products, except INH and also proposes to set up a new plant for the
 manufacture of Glyoxal and Ammonium Sulphate. The Company has been
 consistently making profits and has maintained an unbroken dividend
 record since the year 1990-91.
 
 The Company is a part of the Alchemie Group of Companies. The 
 Company is promoted by Mr. Chandrakant V.Gogri, Mr.Rajendra V.Gogri
 and Mr. Shantilal T. Shah. Mr. P.M. Patil and Mr. S. P. Nachane
 joined the Group  in 1981. The Alchemie Group is a professionally
 managed, multi-product, multilocation Group comprising 24
 manufacturing units with a total turnover of over Rs.100
 crores for the year 1991-92. The products of the Group, exceeding 40,
 range from industrial chemicals and dye intermediates to bulk drugs
 and fine chemicals. The Group's customer list includes most of the
 leading chemical companies in the country. The Group's turnover and
 profits have increased five-fold in the last 5 years. It also
 recorded an export turnover of more than Rs. 30 crores in the year
 1991-92. The Group units export products mainly to the  general 
 currency areas such as USA, UK, Switzerland and Germany.
 
 
 2000 - The Company proposed to acquire 15,31,000 No. of equity shares
 of 
             Alchemie Organics Ltd 33.44 per cent of the total paid-up
 capital of AOL
              held by the other promoters.
 
 2002-Gauri Balankhe appointed as Compliance Officer of Aarti Drugs.
 
 2004
 
 -Aarti Drugs Ltd. has informed that the Company has changed its
 Registrar and Share Transfer Agent and Depository interface for
 Handling Depository related operations by appointing M/s Sharepro
 Services in place of M/s R & D Consultants Ltd w.e.f. January 16,
 2004 subject to completion of necessary formalities as maybe
 prescribed in this regard. The address and telephone number of M/s
 Sharepro Services for all investors related services are as under: 1.
 M/s Sharepro Services, Unit : Aarti Drugs Ltd; 912, Raheja Centre,
 Free Press Journal Road, Nariman Point, Mumbai 400 021, Tel nos :
 22881569, 22884527. 2. M/s Sharepro Services, Unit : Aarti Drugs Ltd;
 912, Satam Estate, 3rd Floor, Above Bank of Baroda, Chakla, Andheri
 (East), Mumbai 400 099, Tel nos : 28215168, 28319828; Fax nos :
 28375646.
 
 -Aarti bags European certification for three drugs
 
 -Delist from Ahmedabad Stock Exchange (ASE) with effect from October
 15, 2004.
 
 
 2006
 
 -Aarti Drugs enters into JV with API Manufacturing Chinese Company
 
 - Aarti Drugs Ltd. has informed that Mr. Prakash Khedekar, Company
 Secretary & Compliance Officer of the Company has resigned from the
 position of Company Secretary & Compliance Officer  with effect from
 October 31, 2006. Further, Mrs. Mona Patel, possessing requisite
 qualifications, has been appointed as Company Secretary & Compliance
 Officer of the Company with effect from November 01, 2006.
 
 2009
 
 - Aarti Drugs Ltd has has appointed Shri Krishnacharya Govindacharya
 Akamanchi & Prof. Sudhir Prakash B. Sawant as Independent Directors
 of the Company.
 
 2010
 
 -Aarti Drugs has recommended dividend of Rs. 5/- (50%) per share
 
 2011
 
 -Mr. Sunny D. Pagare, has been appointed as Company Secretary &
 Compliance Officer of the Company 
 
 -Aarti Drugs has recommended Final Dividend of Rs. 2.5 /-per share
 (25%)
 
 2012
 
 -Mr. Adhish P. Patil, has been appointed as Chief Financial Officer
 of the Company 
 
 -Aarti Drugs has declared Final dividend Rs. 3.00 (30%) per share
 
 2013
 -Aarti Drugs has recommended a Final Dividend of Rs. 4/- per share on
 Equity Shares of Rs. 10/- each.
 
 2014
 -Aarti Drugs has commenced the new R&D center at MIDC Tarapur.
 -Aarti Drugs has recommended a Final dividend @ Rs. 5.50 ps. (55%)
 per share.
 
 2015
 -Aarti Drugs Ltd has  will participate at 'Centrum Pharma Day'
 Investor Conference
 -The Company has allotted the Bonus Shares to its shareholders in the
 Ratio of 1:1.